3 Compelling Reasons to Buy Teladoc Stock Now That the Livongo Deal Is Done
It's now a done deal. Teladoc Health (NYSE: TDOC) completed its merger with Livongo Health last week. The combination of the two companies, first announced on Aug. 5, 2020, wrapped up in less than three months.
Many investors haven't been happy about the merger of Teladoc and Livongo. I'm not one of them. My view is that the combination has created the strongest virtual care provider on the market. I also think Teladoc remains a great stock to buy now that the Livongo deal has closed. Here are three compelling reasons why.
Image source: Getty Images.
Source Fool.com